Atrial natriuretic peptide attenuates ANG II-induced hypertrophy of renal tubular cells (Q40799480)

23 September 2017

title

Atrial natriuretic peptide attenuates ANG II-induced hypertrophy of renal tubular cells (English)

1 reference

atrial natriuretic peptide

23 September 2017

main subject

0 references

author name string

Hannken T

1

1 reference

23 September 2017

Schroeder R

2

1 reference

23 September 2017

Stahl RA

3

1 reference

23 September 2017

Wolf G

4

1 reference

23 September 2017

publication date

1 July 2001

1 reference

American Journal of Physiology - Renal Physiology

23 September 2017

published in

1 reference

23 September 2017

volume

281

1 reference

23 September 2017

issue

1

1 reference

23 September 2017

page(s)

F81-90

1 reference

Natriuretic peptides inhibit DNA synthesis in cardiac fibroblasts.

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2001.281.1.F81

Angiotensin II-mediated expression of p27Kip1 and induction of cellular hypertrophy in renal tubular cells depend on the generation of oxygen radicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2001.281.1.F81

Atrial natriuretic peptide inhibits angiotensin-stimulated proximal tubular sodium and water reabsorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2001.281.1.F81

Regulation of S6 kinase activity in renal proximal tubule.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2001.281.1.F81

Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2001.281.1.F81

Interaction of atrial natriuretic polypeptide and angiotensin II on protooncogene expression and vascular cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2001.281.1.F81

Blood pressure-independent effects in rats with human renin and angiotensinogen genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2001.281.1.F81

Atrial natriuretic peptide inhibits mitogen-activated protein kinase through the clearance receptor. Potential role in the inhibition of astrocyte proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2001.281.1.F81

Cell cycle regulatory proteins in renal disease: role in hypertrophy, proliferation, and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2001.281.1.F81

Characterization of natriuretic peptide receptors in cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2001.281.1.F81

MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2001.281.1.F81

Inhibition of Ras-induced DNA synthesis by expression of the phosphatase MKP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2001.281.1.F81

Molecular mechanisms of angiotensin II in the kidney: emerging role in the progression of renal disease: beyond haemodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2001.281.1.F81

Vasoactive factors and tubulointerstitial injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2001.281.1.F81

Angiotensin II-stimulated hypertrophy of LLC-PK1 cells depends on the induction of the cyclin-dependent kinase inhibitor p27Kip1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2001.281.1.F81

Angiotensin-converting enzyme inhibitor therapy for non-diabetic progressive renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2001.281.1.F81

Purification, sequencing and synthesis of natriuretic and vasoactive rat atrial peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2001.281.1.F81

10.1152/AJPRENAL.2001.281.1.F81

21 January 2018

Identifiers

DOI

0 references

1 reference